Long Island Osteochondral Defect Lawyer

An osteochondral defect (OCD) is an injury to the articular cartilage — the smooth hyaline cartilage that covers the surfaces of joints — with or without damage to the underlying subchondral bone. The word "osteochondral" combines the Greek roots for bone (osteo) and cartilage (chondral), reflecting that these injuries involve the joint surface at the interface between the two tissues. Car accidents are a leading cause of traumatic osteochondral defects: direct impaction against the dashboard, steering wheel, or door panel; torsional forces in rollover collisions; and axial loading through the lower extremity in frontal crashes can all generate impaction forces sufficient to damage or destroy articular cartilage.

The clinical significance of osteochondral defects lies in the biology of articular cartilage: hyaline cartilage has no blood supply, no nerve supply, and no lymphatic vessels, giving it essentially no intrinsic capacity to heal. Once the cartilage surface is damaged, the defect does not regenerate, and the joint surface is permanently altered. Post-traumatic osteoarthritis — the progressive joint degeneration that follows articular cartilage injury — develops in 40 to 70 percent of patients at 10-year follow-up regardless of treatment, ultimately requiring joint replacement surgery in many cases.

Our Long Island personal injury attorneys have represented cartilage injury victims for over 24 years, recovering verdicts and settlements in cases involving talar osteochondral defects, knee cartilage injuries, shoulder impaction lesions, and the full spectrum of cartilage repair surgery from microfracture through MACI. We understand the Outerbridge and Berndt and Harty classification systems, MRI cartilage imaging, and the long-term consequences of post-traumatic arthritis that drive the highest damages in these cases.

Articular Cartilage Biology: Why Osteochondral Defects Do Not Heal

Articular (hyaline) cartilage is a specialized connective tissue composed of chondrocytes (cartilage cells) embedded in an extracellular matrix of collagen type II fibers and proteoglycans (primarily aggrecan). The proteoglycan matrix carries a large negative charge that attracts water, giving cartilage its viscoelastic properties — the ability to absorb and distribute compressive loads across the joint surface. The collagen framework provides tensile strength to resist shear forces during joint motion.

Unlike virtually all other musculoskeletal tissues, articular cartilage is completely avascular — it has no blood vessels. Chondrocytes receive nutrition by diffusion from the synovial fluid that bathes the joint surface. This unique metabolic arrangement means that when cartilage is injured, the vascular inflammatory response that repairs other tissues cannot occur within the cartilage itself. There are no blood vessels to deliver fibroblasts, macrophages, growth factors, or stem cells to the injury site.

The ICRS (International Cartilage Repair Society) classification is an alternative grading system using Grades 0 through 4 that parallels the Outerbridge scale and is commonly used in the research literature and in operative reports from fellowship-trained sports medicine surgeons. Grade 0 is normal cartilage; Grade 1 corresponds to Outerbridge Grade I; Grade 2 to Outerbridge Grade II; Grade 3 to Outerbridge Grade III; and Grade 4 to Outerbridge Grade IV. Both classification systems are used in litigation, and the treating orthopedic surgeon's operative report documenting the intraoperative Outerbridge or ICRS grade is the most authoritative staging evidence available.

How Car Accidents Cause Osteochondral Defects

Most Common Osteochondral Defect Sites in Car Accident Victims

Talar Osteochondral Defects (Ankle)

The talus is the most common bone affected by osteochondral defects in car accident victims. The talar dome — the rounded superior surface of the talus that articulates with the tibial plafond — has one of the thickest articular cartilage surfaces in the body (1.5 to 2.5 mm), yet sustains some of the highest unit loads in the lower extremity. Posteromedial talar osteochondral defects (accounting for 60 to 70% of traumatic talar OCDs) arise from ankle supination injuries during the collision and are typically cup-shaped, deep, and associated with subchondral cyst formation. Anterolateral talar OCD (30 to 40%) arises from ankle pronation or direct impact and tends to be shallower and more wafer-like in configuration. The Berndt and Harty classification stages talar OCDs from Stage I (subchondral compression) through Stage IV (displaced loose body).

Knee Osteochondral Defects (Medial Femoral Condyle and Patella)

The medial femoral condyle is the most common site of knee osteochondral defects from car accidents because it bears the majority of weight during the stance phase of walking and is the primary surface impacted during axial loading through the tibial plateau. The classic mechanism is direct dashboard impact driving the tibial plateau upward against the medial femoral condyle. MRI with cartilage-sensitive sequences is essential for staging; the distinction between a bone bruise (T2 hyperintensity in bone marrow without articular surface disruption) and a true osteochondral defect (articular cartilage disruption confirmed on fat-suppressed PD sequences) is critical because bone bruises resolve while osteochondral defects do not.

Patellar osteochondral defects arise from direct dashboard impact to the front of the knee, compressing the patella against the trochlear groove of the femur. Patellar cartilage injury can progress to patellofemoral arthritis — a painful degenerative condition of the kneecap joint that causes chronic anterior knee pain with stair climbing, prolonged sitting, and squatting.

Shoulder and Hip Osteochondral Defects

Hill-Sachs lesions of the humeral head arise from glenohumeral subluxation or dislocation during rollover or direct shoulder impact. Pipkin fractures — femoral head osteochondral fractures from hip dislocation — occur in high-energy frontal crashes when the knee impacts the dashboard and the posterior hip capsule tears; the femoral head fractures against the acetabular rim as the hip is driven posteriorly. Pipkin fractures are classified into four types based on the location of the femoral head fragment relative to the fovea centralis; Pipkin Types III and IV (associated with acetabular fracture or femoral neck fracture) carry the worst prognosis for avascular necrosis and post-traumatic arthritis.

Diagnosis: Why X-Rays Miss Cartilage Injuries

Articular cartilage is radiolucent — it does not absorb X-ray beams and therefore does not appear on plain X-ray films. An emergency physician or primary care physician evaluating joint pain after a car accident with normal plain X-rays (no fracture) may conclude that no significant injury is present. This diagnostic error delays treatment and allows osteochondral fragments to progress from stable to unstable — from non-displaced (Stage II-III) to displaced (Stage IV) — while the window for optimal cartilage repair surgery narrows.

MRI is the gold standard for diagnosing osteochondral defects. Fat-suppressed proton-density (PD) sequences and T2-weighted sequences reveal cartilage signal abnormalities, subchondral bone edema, and fragment position with high sensitivity. High-resolution 3.0 Tesla MRI with dedicated small-joint protocols is preferred for the ankle and shoulder. For cartilage staging in the knee, T2-mapping and dGEMRIC sequences provide quantitative information about cartilage biochemistry that standard morphological sequences miss.

Diagnostic arthroscopy remains the gold standard for definitive osteochondral defect staging — the arthroscope allows direct visualization and probing of the cartilage surface under magnification, enables accurate Outerbridge grading, and can be combined with therapeutic intervention (microfracture, loose body removal, OATS) in a single procedure. The operative report from arthroscopy documenting the Outerbridge grade, defect dimensions, and defect location is the most authoritative evidence of injury severity available in osteochondral defect litigation.

Treatment Options: From Conservative Care to Articular Cartilage Reconstruction

Conservative Management — Stable Lesions Under 1 Square Centimeter

Small stable osteochondral lesions (Grade I-II, less than 1 cm²) may be managed conservatively with protected weight bearing (crutches, cam walker boot for ankle lesions), anti-inflammatory medications, and physical therapy focused on joint range of motion, proprioception, and periarticular muscle strengthening. The goal of conservative management is to reduce joint loading on the damaged cartilage surface, minimize synovial inflammation, and maintain joint mobility while the injury stabilizes. Conservative treatment does not repair the cartilage defect; it manages symptoms and may prevent progression in small stable lesions. Serial MRI at 3 and 6 months monitors lesion stability.

Microfracture — Arthroscopic Bone Marrow Stimulation for Defects Under 2 Square Centimeters

Microfracture is the most commonly performed cartilage repair procedure. The surgeon uses an arthroscopic awl to create multiple small perforations in the exposed subchondral bone at 3 to 4 millimeter intervals throughout the defect. Marrow contents — stem cells, growth factors, and fibrin — bleed into the defect and form a super-clot that differentiates into fibrocartilage over 6 to 8 weeks under protected non-weight-bearing conditions. Microfracture is best suited for defects less than 2 cm² in non-weight-bearing or low-load areas; outcomes are generally good at 2 to 5 years but show documented deterioration at 5 to 10 years as the mechanically inferior fibrocartilage wears down. The 6 to 8 week non-weight-bearing recovery period satisfies the 90/180 day serious injury threshold in virtually all cases.

OATS Mosaicplasty — Osteochondral Autograft Transfer for Defects Under 4 Square Centimeters

OATS (osteochondral autograft transfer system) and mosaicplasty harvest cylindrical plugs of intact bone and hyaline cartilage from low-weight-bearing donor areas of the same joint — typically the lateral trochlear groove or intercondylar notch of the knee — and press-fit them into the osteochondral defect. Single-stage arthroscopic or mini-open procedure; produces true hyaline cartilage fill of the defect; best for defects between 1 and 4 cm². Donor site morbidity is an important consideration: the harvest sites leave osteochondral defects at the donor area that can produce their own symptoms of knee pain and stiffness. Cost: $15,000 to $35,000 for the procedure. Six to 8 weeks non-weight-bearing recovery.

MACI / ACI — Autologous Chondrocyte Implantation for Large Defects Over 4 Square Centimeters

Autologous chondrocyte implantation (ACI) and its modern iteration matrix-associated autologous chondrocyte implantation (MACI) require two surgical stages. Stage 1: a small arthroscopic biopsy harvests 200 to 300 mg of articular cartilage from a low-weight-bearing area of the joint; chondrocytes are isolated and cultured in a cell processing laboratory over 3 to 6 weeks, expanding the cell count 10 to 30-fold. Stage 2: the cultured chondrocytes are seeded onto a porcine type I/III collagen scaffold (MACI) or injected under a periosteal patch (traditional ACI) and implanted into the prepared cartilage defect during an open arthrotomy. The scaffold-based MACI technique (FDA-approved in 2016) has replaced traditional ACI as the standard approach in the United States. MACI produces tissue approaching true hyaline cartilage biochemistry and is best for large defects greater than 4 cm² or failed prior procedures. Recovery: 6 to 12 weeks protected weight bearing after Stage 2, followed by 12 to 18 months of progressive physical therapy; athletes typically require 18 months before return to sport. Cost: $25,000 to $45,000 for cell processing alone, plus Stage 2 surgery costs.

Fresh Osteochondral Allograft and Salvage Procedures

Fresh osteochondral allograft transplantation uses a cadaveric osteochondral graft — sourced from a tissue bank within 28 days of donor death to preserve chondrocyte viability — to replace large, complex, or previously failed cartilage defects. Allograft can treat defects too large for OATS donor availability and does not require a second-stage cell culture procedure. Salvage procedures for end-stage post-traumatic arthritis include patellofemoral arthroplasty, unicompartmental knee replacement, total knee replacement ($35,000 to $65,000), and tibiotalar ankle arthrodesis (fusion, $25,000 to $50,000) for end-stage ankle OCD. These joint replacement procedures represent the final definitive treatment when cartilage repair has failed and arthritis is disabling, and they anchor the future damages calculation in the most severe osteochondral defect cases.

Osteochondral Defect Case Results

Past results do not guarantee future outcomes. Each case is unique and depends on the specific facts, available insurance coverage, and extent of documented injury.

New York Law and Osteochondral Defect Claims

Under New York Insurance Law Section 5102(d), osteochondral defects can satisfy the serious injury threshold under multiple categories. The "permanent consequential limitation of use of a body function or system" category is established when MRI documents an osteochondral defect with articular cartilage loss, the treating orthopedic surgeon documents objective range-of-motion limitation (quantified in degrees) consistently on serial examinations, and the physician opines that the cartilage injury is permanent and that post-traumatic arthritis is expected or already documented. Articular cartilage surgery — microfracture, OATS, or MACI — provides compelling objective evidence of injury severity; courts routinely find that surgical intervention satisfies the permanent consequential limitation threshold.

The "significant limitation of use of a body function or system" category is satisfied by Grade II lesions with documented range-of-motion limitation or functional deficit documented consistently on serial objective examinations. A chondral injury without osseous involvement — affecting only the cartilage without subchondral bone changes visible on MRI — may face threshold challenges in the absence of objective findings; the treating physician must document range-of-motion limitation in degrees, specific functional deficits (inability to perform named activities), and the relationship between the MRI findings and the functional limitations. An osteochondral defect with a subchondral bone component is better positioned to satisfy the objective evidence requirement because the bony changes are visible on both MRI and potentially on plain X-ray.

The 90 of 180 days threshold is readily satisfied in cases requiring microfracture (6 to 8 weeks strict non-weight-bearing), OATS (6 to 8 weeks non-weight-bearing), or MACI Stage 2 surgery (6 to 12 weeks protected weight bearing plus 12 to 18 months physical therapy). An osteochondral defect combined with a fracture — such as a talar OCD with an associated fibular fracture or a knee OCD with a tibial plateau fracture — satisfies the fracture category independently, removing the threshold issue from the case entirely. Our Long Island car accident lawyer team handles osteochondral defect cases with the orthopedic, radiological, and biomechanical expert resources that cartilage injury litigation requires.

Future damages in osteochondral defect cases are among the most substantial in orthopedic injury litigation. Post-traumatic osteoarthritis developing at 10-year follow-up — documented in 40 to 70% of patients with significant OCD regardless of treatment — requires joint replacement surgery costing $35,000 to $65,000 for total knee replacement or $25,000 to $50,000 for tibiotalar fusion. A life care plan quantifying these future costs, supported by a treating orthopedic surgeon's prognosis opinion and presented through a certified life care planner and economic expert, can dramatically increase the total damages recovery. The statute of limitations is three years under CPLR Section 214; no-fault applications must be filed within 30 days of the accident.

Frequently Asked Questions — Osteochondral Defect Cases